- Previous Close
10.80 - Open
10.30 - Bid --
- Ask --
- Day's Range
10.30 - 10.60 - 52 Week Range
9.25 - 19.90 - Volume
5 - Avg. Volume
28 - Market Cap (intraday)
616.225M - Beta (5Y Monthly) 1.18
- PE Ratio (TTM)
12.18 - EPS (TTM)
0.87 - Earnings Date May 7, 2025 - May 12, 2025
- Forward Dividend & Yield 0.55 (5.12%)
- Ex-Dividend Date Feb 28, 2025
- 1y Target Est
--
Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes in the United States and internationally. The company's products include pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing patient's diabetes. It primarily sells its products to wholesalers and distributors. The company was formerly known as Berra Newco, Inc. Embecta Corp. was founded in 1924 and is headquartered in Parsippany, New Jersey.
www.embecta.com2,100
Full Time Employees
September 30
Fiscal Year Ends
Sector
Medical Instruments & Supplies
Industry
Recent News: JX7.F
View MorePerformance Overview: JX7.F
Trailing total returns as of 4/15/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: JX7.F
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: JX7.F
View MoreValuation Measures
Market Cap
609.97M
Enterprise Value
1.82B
Trailing P/E
12.37
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.65
Price/Book (mrq)
--
Enterprise Value/Revenue
1.86
Enterprise Value/EBITDA
11.40
Financial Highlights
Profitability and Income Statement
Profit Margin
5.25%
Return on Assets (ttm)
3.13%
Return on Equity (ttm)
--
Revenue (ttm)
1.11B
Net Income Avi to Common (ttm)
58.2M
Diluted EPS (ttm)
0.87
Balance Sheet and Cash Flow
Total Cash (mrq)
210M
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
-37.41M